XTL BIOPHARMACEUTICALS LTD. Equity
XTL BIOPHARMACEUTICALS LTD. (XTLB) had Equity of $5.43 million as of 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:Equity · last filed 2025-04-30
- 2024-12-31: Equity $5.43M.
- 2023-12-31: Equity $2.22M.
- 2022-12-31: Equity $4.00M.
- 2022-06-30: Equity $5.56M.
| Period end | Equity | Equity as first filed |
|---|---|---|
| 2024-12-31 | $5.43M 20-F · filed 2025-04-30 | |
| 2023-12-31 | $2.22M 20-F · filed 2025-04-30 | |
| 2022-12-31 | $4.00M 20-F · filed 2025-04-30 | |
| 2022-06-30 | $5.56M 6-K · filed 2022-08-24 | |
| 2021-12-31 | $5.33M 20-F · filed 2025-04-30 | |
| 2021-06-30 | $3.28M 6-K · filed 2022-08-24 | |
| 2021-03-31 | $4.37M 6-K · filed 2021-08-24 | |
| 2020-12-31 | $3.61M 20-F · filed 2023-03-22 | $6.25M 20-F · filed 2021-03-15 |
| 2020-06-30 | $5.59M 6-K · filed 2021-08-24 | |
| 2020-03-31 | $6.71M 6-K · filed 2021-08-24 | |
| 2019-12-31 | $6.51M 20-F · filed 2023-03-22 | $6.98M 20-F · filed 2020-03-12 |
| 2019-01-01 | $7.27M 20-F/A · filed 2021-05-19 | |
| 2018-12-31 | $7.27M 20-F · filed 2022-03-30 | $8.32M 20-F · filed 2019-03-11 |
| 2017-12-31 | $3.62M 20-F/A · filed 2021-05-19 | |
| 2016-12-31 | $2.69M 20-F · filed 2020-03-12 | |
| 2015-12-31 | $4.89M 20-F · filed 2019-03-11 | |
| 2014-12-31 | $4.68M 20-F · filed 2018-03-15 |